Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

AI app put to the test: can it help ER doctors spot medication mishaps?

NCT ID NCT05952193

First seen Jun 17, 2026 · Last updated Jun 23, 2026 · Updated 2 times

Summary

This study tested whether the POSOS app, an AI tool, helps emergency doctors detect drug-induced harm (iatrogenesis) in simulated patient cases. 85 doctors were randomly assigned to use the app or not, and their accuracy was measured at 5 and 15 minutes. The goal is to see if such technology can improve diagnostic safety in urgent care.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ARTIFICIAL INTELLIGENCE are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • CHU Amiens

    Amiens, 80480, France

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

POSOS app (artificial intelligence tool for medical information search)

What this could lead to

If successful, this could point toward a reliable AI tool that helps emergency doctors spot drug-related problems faster, potentially reducing medical errors.

What could go wrong

This is a small, completed simulation study with 85 participants, not a real-world patient trial. The results may not translate to actual emergency settings or general practice.

Conditions

The condition(s) this trial relates to.

iatrogenic disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.